RECALL OF HEPATITIS B DRUG BY CIPLA QUALITY CHEMICAL INDUSTRIES LTD
Cipla Quality Chemical Industries Limited Bell Ringing and First Day of Trading on the Uganda Securities Exchange
September 19, 2018

PRESS STATEMENT: RECALL OF HEPATITIS B DRUG BY CIPLA QUALITY CHEMICAL INDUSTRIES LTD

Referenceis made to several media reports that have been circulating in regard to the recall of Texavir, a Tenofovir baseddrug for the managementof hepatitis B manufactured by Cipla Quality Chemical Industries Ltd (CiplaQCIL). View full statement